| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/03/1999 | US5932238 Galanthamine containing transdermal applicator for the treatment of alcoholism |
| 08/03/1999 | US5932236 Pharmaceutical composition and methods for using it |
| 08/03/1999 | US5932235 Jellied medicinal composition for oral administration |
| 08/03/1999 | US5932232 Product for topical application containing a lipase and an active ingredient precursor |
| 08/03/1999 | US5932227 Percutaneously administrable base composition and drug composition prepared therefrom |
| 08/03/1999 | US5932215 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema |
| 08/03/1999 | US5932205 Biochemical contact lens for treating photoablated corneal tissue |
| 08/03/1999 | US5931809 Epidural administration of therapeutic compounds with sustained rate of release |
| 08/03/1999 | CA2149659C Method of applying an indicia to a fast-dissolving dosage form |
| 08/03/1999 | CA2061998C Magnesium carbonate and oil tableting aid |
| 08/03/1999 | CA1340694C Biodegradable in-situ forming implants and methods of producing the same |
| 08/03/1999 | CA1340692C Method of potentiating an immune response and compositions therefor |
| 07/29/1999 | WO1999037760A1 Inhibition of cytokine production |
| 07/29/1999 | WO1999037678A2 Antimicrobial peptides |
| 07/29/1999 | WO1999037335A1 Apparatuses and processes for whole-body hyperthermia |
| 07/29/1999 | WO1999037325A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
| 07/29/1999 | WO1999037319A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | WO1999037311A1 Cellulose derivatives and colorectal cancer risk reduction |
| 07/29/1999 | WO1999037310A1 Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 07/29/1999 | WO1999037308A1 Method for producing a medicament which quickly dissolves in the mouth and which contains acarbose as an active agent |
| 07/29/1999 | WO1999037302A1 Extended release tiagabine formulations with reduced side-effects |
| 07/29/1999 | WO1999037301A1 New use for pain management |
| 07/29/1999 | WO1999037300A1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers |
| 07/29/1999 | WO1999037297A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 07/29/1999 | WO1999037290A1 Novel dosage form |
| 07/29/1999 | WO1999037289A1 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| 07/29/1999 | WO1999037288A1 Lyophilization method for sustained-release preparations |
| 07/29/1999 | WO1999037286A1 Fluorometholone suspension eye drops |
| 07/29/1999 | WO1999037285A1 Water dispersible polysaccharide particles |
| 07/29/1999 | WO1999037282A2 Reduced lipid flowable cosmetic or dermatological preparations |
| 07/29/1999 | WO1999037275A2 COSMETIC OR PHARMACEUTICAL PREPARATIONS WITH A LESS STICKY FEEL, CONTAINING GLYCERIN ESTERS OF α-HYDROXY CARBOXYLIC ACIDS AND SATURED FATTY ACIDS |
| 07/29/1999 | WO1999037273A2 Cosmetic and dermatological preparations containing higher electrolyte concentrations |
| 07/29/1999 | WO1999024016A8 Emulsions for aerosolization and drug delivery |
| 07/29/1999 | WO1999008500A3 New crystalline form of omeprazole |
| 07/29/1999 | DE19802708A1 Use of 1-hydroxy-2-pyridone compounds with powder base for treatment of lower leg ulcers and decubitus ulcers |
| 07/29/1999 | DE19802700A1 Preparation of fast-dissolving tablets for controlling blood sugar levels |
| 07/29/1999 | DE19802206A1 Stable cosmetic or dermatological composition with low viscosity |
| 07/29/1999 | DE19802205A1 Cosmetic or dermatological composition with electrolyte-containing aqueous phase, stable against phase separation, e.g. sunscreens |
| 07/29/1999 | DE19802204A1 Cosmetic or pharmacological oil in water emulsions with reduced stickiness |
| 07/29/1999 | CA2318642A1 Fluorometholone ophthalmic suspension |
| 07/29/1999 | CA2318448A1 Extended release tiagabine formulations with reduced side-effects |
| 07/29/1999 | CA2318263A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | CA2318257A1 Novel dosage form |
| 07/29/1999 | CA2317839A1 Inhibition of cytokine production |
| 07/29/1999 | CA2317744A1 Cellulose derivatives and colorectal cancer risk reduction |
| 07/29/1999 | CA2317577A1 Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 07/29/1999 | CA2260610A1 Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| 07/28/1999 | EP0931552A2 Process for preparation of solid dosage forms |
| 07/28/1999 | EP0931546A1 Percutaneous absorption preparation comprising an antiparkinsonian drug |
| 07/28/1999 | EP0931543A1 Multilayered tablet comprising probiotic microorganisms such as lactobacilli or bifidobacteria |
| 07/28/1999 | EP0930937A1 Microbeads prepared from cross-linked polysaccharide hydrogel capable of containing molecules of biological interest or cells |
| 07/28/1999 | EP0930936A1 Method for preparing microcapsules of active substances coated with a polymer and novel microcapsules in particular resulting from the method |
| 07/28/1999 | EP0930933A1 Method for releasing an active principle contained in a multiple emulsion |
| 07/28/1999 | EP0930892A1 Cytokine enhanced immunotherapy for brain tumors |
| 07/28/1999 | EP0930888A1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 07/28/1999 | EP0930886A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 07/28/1999 | EP0930880A1 Pharmaceutical composition comprising a combination of isosorbide nitrate with acetylsalicylic acid |
| 07/28/1999 | EP0930878A1 Use of sodium 2-mercaptoethanesulfonate in surgery |
| 07/28/1999 | EP0930875A2 Process for producing solid dosage forms by extrusion |
| 07/28/1999 | EP0930874A2 A method for producing a microparticle |
| 07/28/1999 | EP0930873A1 Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
| 07/28/1999 | EP0930870A1 Preparation protecting skin from mechanical irritation |
| 07/28/1999 | EP0930830A1 Oil containing lipid vesicles with marine applications |
| 07/28/1999 | EP0865463B1 Process for the preparation of porous polyyolefin particles |
| 07/28/1999 | EP0630286B1 Pharmaceutical or cosmetic oil-in-water emulsions of positively charged particles |
| 07/28/1999 | EP0565604B1 Catheter for drug delivery system |
| 07/28/1999 | CN2330361Y 片剂胶囊 Tablets Capsules |
| 07/28/1999 | CN1224360A Hydrophobic preparations contg. medium chain monoglycerides |
| 07/28/1999 | CN1224357A Aqueous formulations of peptides |
| 07/28/1999 | CN1224356A Non-aqueous protic peptide formulations |
| 07/28/1999 | CN1224355A Injections contg. lipid A analogues and process for preparation thereof |
| 07/28/1999 | CN1224351A Pharmaceutical preparation contg. nimesulide for oral administration |
| 07/28/1999 | CN1224349A Intraorally rapidly disintegrable tablet |
| 07/28/1999 | CN1224348A Granulate for preparation of fast-disintegrating and fast-dissolving compositions contg. high amount of drug |
| 07/28/1999 | CN1224347A High dose liposomal aerosol formulations |
| 07/28/1999 | CN1224346A Lubrication assistant and process for preparation of ethyl stearate used therein |
| 07/28/1999 | CN1223884A Chilblain ointment and preparing method thereof |
| 07/28/1999 | CN1223881A Zinc-contg. haw oral liquid and its preparing process |
| 07/28/1999 | CN1223880A Medicine for treating cervical erosion and method for preparing same |
| 07/28/1999 | CN1223868A Hepatitis B tablet and its preparing process |
| 07/28/1999 | CN1223858A Technique for synergism of cigarette to make it have Yin-nourishing, Yang-strengthening, anti asthmatic and anticancer functions |
| 07/28/1999 | CN1223857A Yinkangshuan suppository for vaginal diseases |
| 07/28/1999 | CN1044319C Hot melt antihistamine formulations preparing process |
| 07/27/1999 | US5929196 Polyesters of a polyhydroxycarboxylic acid and a polyol having a substituent with electrolyte properties |
| 07/27/1999 | US5929177 Block polymer having functional groups at both ends |
| 07/27/1999 | US5929115 Aqueous mixture containing diclofenac sodium, cyclodextrin, polyvinyl pyrrolidone and one of benzethonium chloride or benzalkonium chloride; storage stability |
| 07/27/1999 | US5929051 Aloe pectin contains 3-o-methyl rhamnose, being capable of forming gel in presence of calcium salt; temperature reversible forms solution at room temperature; used as controlled release agent |
| 07/27/1999 | US5929048 Treatment of conditions and disease |
| 07/27/1999 | US5929044 Composition comprising a protein solder, a bioactive compound, and a vehicle for delivering said bioactive compound into a target cell having a genome, wherein said vehicle is a virus or a liposome |
| 07/27/1999 | US5929040 Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 07/27/1999 | US5929030 Pharmaceutical compositions |
| 07/27/1999 | US5929028 Liquid gonadotropin containing formulations |
| 07/27/1999 | US5929027 Physiologically active polypeptide-containing pharmaceutical composition |
| 07/27/1999 | US5928958 Superparamagnetic particles, process for their manufacture and usage |
| 07/27/1999 | US5928944 Method of adenoviral-medicated cell transfection |
| 07/27/1999 | US5928709 Process for the preparation of low molecular weight cellulose ethers |
| 07/27/1999 | US5928706 Particles comprising gelatin, carbohydrates, phospholipids crosslinked by phenolic acid; fat substitutes |
| 07/27/1999 | US5928669 Lymphatic delivery methods |
| 07/27/1999 | US5928668 Method for dry blend compression of medicaments |
| 07/27/1999 | US5928667 Drug delivery device and method for employing the same |